Celiac Artery Stenting to Facilitate Hepatic Yttrium-90 Radioembolization Therapy

  • Chamarthy M
  • Hughes T
  • Gupta M
  • et al.
N/ACitations
Citations of this article
13Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Radioembolization offers a novel way to treat the nonresectable, liver predominant hepatic malignancies with better tumor response and overall progression-free survival rates. Transarterial catheter-based radioembolization procedure involves the hepatic arterial administration of glass- or resin-based beta emitting Yttirum-90 microspheres. Safe delivery of the tumoricidal radiation dose requires careful angiogram planning and coil embolization to quantify lung shunting and prevent systemic toxicity, respectively. Diagnostic pretreatment angiogram also serves to identify the hepatic arterial variant anatomy and other coexisting pathologies that might require a different or alternative approach. We describe a complex case of celiac artery stenosis with tortuous pancreaticoduodenal arterial arcade precluding access to the right hepatic artery for performing radioembolization. Celiac artery stenting of the stenosis was performed to facilitate subsequent safe and successful Yttrium-90 microsphere radioembolization.

Cite

CITATION STYLE

APA

Chamarthy, M. R., Hughes, T. W., Gupta, M., Vossen, J. A., Velasco, N. B., & Zinn, K. M. (2012). Celiac Artery Stenting to Facilitate Hepatic Yttrium-90 Radioembolization Therapy. Case Reports in Radiology, 2012, 1–5. https://doi.org/10.1155/2012/236732

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free